Computational methods and systems for augmenting cell-mediated immune response
The present application relates, in general, to a system and/or method related to detection and/or treatment.
1 . A system comprising:
at least one computer program for use with at least one computer system and wherein the computer program includes a plurality of instructions including but not limited to:
one or more instructions for identifying an association of at least a computable portion of one or more agents with at least a part of an immune response;
one or more instructions for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents; and
one or more instructions for selecting one or more immune response components in response to the projecting.
2 . The system of claim 1 , wherein the one or more instructions for identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:
one or more instructions for identifying an association of at least a computable portion of at least one of: a pathogen, a virus, a bacterium, a toxin, a prion, or a cell.
3 . The system of claim 1 , wherein the one or more instructions for identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:
one or more instructions for identifying an association of at least a computable portion of one or more agents with an autoimmune response.
4 . The system of claim 1 , wherein the one or more instructions for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
one or more instructions for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents associated with at least one disease state.
5 . The system of claim 1 , wherein the one or more instructions for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
one or more instructions for projecting a pattern of one or more changes associated with agent pathogenicity.
6 . The system of claim 1 , wherein the one or more instructions for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
one or more instructions for projecting a pattern of one or more changes associated with agent transmission.
7 . The system of claim 1 , wherein the one or more instructions for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
one or more instructions for projecting at least one pattern associated with at least one protein sequence change.
8 . The system of claim 1 , wherein the one or more instructions for selecting one or more immune response components in response to the projecting further comprises:
one or more instructions for selecting at least a part of one or more of an: immune cell, lymphoid cell, myeloid cell, T cell, B cell, or Natural Killer T Cell.
9 . The system of claim 1 , wherein the one or more instructions for selecting one or more immune response components in response to the projecting further comprises:
one or more instructions for selecting one or more modulators of at least a part of one or more of an: immune cell, lymphoid cell, myeloid cell, T cell, B cell, or Natural Killer T Cell.
10 . The system of claim 1 , wherein the one or more instructions selecting one or more immune response components in response to the projecting further comprises:
one or more instructions for selecting at least a part of one or more of an: cell receptor, B cell receptor, antibody, MHC molecule, CD1 molecule, adhesion molecule, cell surface molecule, cell surface receptor, chemokine, cytokine, or autocoid.
11 . The system of claim 1 , wherein the one or more instructions for selecting one or more immune response components in response to the projecting further comprises:
one or more instructions for selecting one or more modulators of at least a part of one or more of an: T cell receptor, B cell receptor, antibody, MHC molecule, CD1 molecule, adhesion molecule, cell surface molecule, cell surface receptor, chemokines, cytokine, or autocoid.
12 . The system of claim 1 , further comprising:
one or more instructions including referencing at least one database.
13 . A system, comprising:
circuitry for identifying an association of at least a computable portion of one or more agents with at least a part of an immune response;
circuitry for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents; and
circuitry for selecting one or more immune response components in response to the projecting.
14 . The system of claim 13 , wherein the circuitry for identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:
circuitry for identifying an association of at least a computable portion of at least one of: a pathogen, a virus, a bacterium, a toxin, a prion, or a cell.
15 . The system of claim 13 , wherein the circuitry for identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:
circuitry for identifying an association of at least a computable portion of one or more agents with an autoimmune response.
16 . The system of claim 13 , wherein the circuitry for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
circuitry for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents associated with at least one disease state.
17 . The system of claim 13 , wherein the circuitry for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
circuitry for projecting a pattern of one or more changes associated with agent pathogenicity.
18 . The system of claim 13 , wherein the circuitry for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
circuitry for projecting a pattern of one or more changes associated with agent transmission.
19 . The system of claim 13 , wherein the circuitry for projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
circuitry for projecting at least one pattern associated with at least one protein sequence change.
20 . The system of claim 13 , wherein the circuitry for selecting one or more immune response components in response to the projecting further comprises:
circuitry for selecting at least a part of one or more of an: immune cell, lymphoid cell, myeloid cell, T cell, B cell, or Natural Killer T Cell.
21 . The system of claim 13 , wherein the circuitry for selecting one or more immune response components in response to the projecting further comprises:
circuitry for selecting one or more modulators of at least a part of one or more of an: immune cell, lymphoid cell, myeloid cell, T cell, B cell, or Natural Killer T Cell.
22 . The system of claim 13 , wherein the circuitry for selecting one or more immune response components in response to the projecting further comprises:
circuitry for selecting at least a part of one or more of an: T cell receptor, B cell receptor, antibody, MHC molecule, CD1 molecule, adhesion molecule, cell surface molecule, cell surface receptor, chemokine, cytokine, or autocoid.
23 . The system of claim 13 , wherein the circuitry for selecting one or more immune response components in response to the projecting further comprises:
circuitry for selecting one or more modulators of at least a part of one or more of an: T cell receptor, B cell receptor, antibody, MHC molecule, CD1 molecule, adhesion molecule, cell surface molecule, cell surface receptor, chemokines, cytokine, or autocoid.
24 . The system of claim 13 , further comprising:
circuitry for referencing at least one database.
25 . A method, comprising:
identifying an association of at least a computable portion of one or more agents with at least a part of an immune response;
projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents; and
selecting one or more immune response components in response to the projecting.
26 . The method of claim 25 , wherein identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:
identifying an association of at least a computable portion of at least one of: a pathogen, a virus, a bacterium, a toxin, a prion, or a cell.
27 . The method of claim 25 , wherein identifying an association of at least a computable portion of one or more agents with at least a part of an immune response further comprises:
identifying an association of at least a computable portion of one or more agents with an autoimmune response.
28 . The method of claim 25 , wherein projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents associated with at least one disease state.
29 . The method of claim 25 , wherein projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
projecting a pattern of one or more changes associated with agent pathogenicity.
30 . The method of claim 25 , wherein projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
projecting a pattern of one or more changes associated with agent transmission.
31 . The method of claim 25 , wherein projecting a pattern of one or more changes relating to the at least a computable portion of one or more agents further comprises:
projecting at least one pattern associated with at least one protein sequence change.
32 . The method of claim 25 , wherein selecting one or more immune response components in response to the projecting further comprises:
selecting at least a part of one or more of an: immune cell, lymphoid cell, myeloid cell, T cell, B cell, or Natural Killer T Cell.
33 . The method of claim 25 , wherein selecting one or more immune response components in response to the projecting further comprises:
selecting one or more modulators of at least a part of one or more of an: immune cell, lymphoid cell, myeloid cell, T cell, B cell, or Natural Killer T Cell.
34 . The method of claim 25 , wherein selecting one or more immune response components in response to the projecting further comprises:
selecting at least a part of one or more of an: T cell receptor, B cell receptor, antibody, MHC molecule, CD1 molecule, adhesion molecule, cell surface molecule, cell surface receptor, chemokine, cytokine, or autocoid.
35 . The method of claim 25 , wherein selecting one or more immune response components in response to the projecting further comprises:
selecting one or more modulators of at least a part of one or more of an: T cell receptor, B cell receptor, antibody, MHC molecule, CD1 molecule, adhesion molecule, cell surface molecule, cell surface receptor, chemokines, cytokine, or autocoid.
36 . The method of claim 25 , further comprising:
referencing at least one database.